APAnn Punnoose

Ann Punnoose

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ann Punnoose has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • US Food and Drug Administration's Advancing Real‐World Evidence Program: Initial Experience

    by Kimberly A. Smith, Yin Huang, Theresa Kehoe, Stefanie Kraus, Mark Levenson, Jie Li, Kristen Miller, Ann Punnoose, Donna R. Rivera, Yueqin Zhao, et al.

    Advances in the availability and analysis of real‐world data (RWD) have enabled the generation of robust real‐world evidence (RWE) to support regulatory decision making by the US Food and Drug Administration. Realizing the full potential of RWE in a regulatory environment requires cross‐discipline expertise and collaboration to increase confidence in RWE‐based approaches. The FDA's Advancing RWE Program was established to address this need by providing a new option for regulatory interactions on RWE‐based approaches.


  • Review of interactions between high‐risk pediatric heart transplant recipients and marginal donors including utilization of risk score models

    by Jeffrey G. Gossett, Shahnawaz Amdani, Sanjeev Khulbey, Ann R. Punnoose, David N. Rosenthal, Jonathan Smith, Jacqueline Smits, Anne I. Dipchand, Richard Kirk, Oliver Miera, et al.

    Background: Donor organ acceptance practices vary among pediatric heart transplant professionals. We sought to understand what is known about the interactions between the “high‐risk” recipient and the “marginal donor,” and how donor risk scores can impact this discussion.Methods: A systematic review of published literature on pediatric HTx was undertaken with the assistance of a medical librarian. Two authors independently assessed search results, and papers were reviewed for inclusion.Results: We found that there are a large number of individual factors, and clusters of factors, that have been used to label individual recipients “high‐risk” and individual donors “marginal.” The terms “high‐risk recipient” and “marginal donor” have been used broadly in the literature making it virtually impossible to make comparisons between publications. In general, the data support that patients who could be easily agreed to be “sicker recipients” are at more risk compared to those who are clearly “healthier,” albeit still “sick enough” to need transplantation. Given this variability in the literature, we were unable to define how being a “high‐risk” recipient interplays with accepting a “marginal donor.” Existing risk scores are described, but none were felt to adequately predict outcomes from factors available at the time of offer acceptance.Conclusions: We could not determine what makes a donor “marginal,” a recipient “high‐risk,” or how these factors interplay within the specific recipient‐donor pair to determine outcomes. Until there are better risk scores predicting outcomes at the time of organ acceptance, programs should continue to evaluate each organ and recipient individually.


  • Sports-Related Sudden Cardiac Injury or Death

    by Elizabeth Anne Greene, Ann Punnoose

    *Corresponding author, E-mail address: EGreene@salud.unm.edu